211 related articles for article (PubMed ID: 24464477)
1. Semaphorin3a signaling, podocyte shape, and glomerular disease.
Tufro A
Pediatr Nephrol; 2014 Apr; 29(4):751-5. PubMed ID: 24464477
[TBL] [Abstract][Full Text] [Related]
2. Excess podocyte semaphorin-3A leads to glomerular disease involving plexinA1-nephrin interaction.
Reidy KJ; Aggarwal PK; Jimenez JJ; Thomas DB; Veron D; Tufro A
Am J Pathol; 2013 Oct; 183(4):1156-1168. PubMed ID: 23954273
[TBL] [Abstract][Full Text] [Related]
3. Semaphorins in kidney development and disease: modulators of ureteric bud branching, vascular morphogenesis, and podocyte-endothelial crosstalk.
Reidy K; Tufro A
Pediatr Nephrol; 2011 Sep; 26(9):1407-12. PubMed ID: 21336944
[TBL] [Abstract][Full Text] [Related]
4. Semaphorin3a regulates endothelial cell number and podocyte differentiation during glomerular development.
Reidy KJ; Villegas G; Teichman J; Veron D; Shen W; Jimenez J; Thomas D; Tufro A
Development; 2009 Dec; 136(23):3979-89. PubMed ID: 19906865
[TBL] [Abstract][Full Text] [Related]
5. Semaphorin3a promotes advanced diabetic nephropathy.
Aggarwal PK; Veron D; Thomas DB; Siegel D; Moeckel G; Kashgarian M; Tufro A
Diabetes; 2015 May; 64(5):1743-59. PubMed ID: 25475434
[TBL] [Abstract][Full Text] [Related]
6. Semaphorin3a disrupts podocyte foot processes causing acute proteinuria.
Tapia R; Guan F; Gershin I; Teichman J; Villegas G; Tufro A
Kidney Int; 2008 Mar; 73(6):733-40. PubMed ID: 18075495
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury.
Sang Y; Tsuji K; Inoue-Torii A; Fukushima K; Kitamura S; Wada J
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32521824
[TBL] [Abstract][Full Text] [Related]
8. Podocyte Shape Regulation by Semaphorin 3A and MICAL-1.
Tufro A
Methods Mol Biol; 2017; 1493():393-399. PubMed ID: 27787866
[TBL] [Abstract][Full Text] [Related]
9. Autocrine class 3 semaphorin system regulates slit diaphragm proteins and podocyte survival.
Guan F; Villegas G; Teichman J; Mundel P; Tufro A
Kidney Int; 2006 May; 69(9):1564-9. PubMed ID: 16541019
[TBL] [Abstract][Full Text] [Related]
10. Semaphorin3a inhibits ureteric bud branching morphogenesis.
Tufro A; Teichman J; Woda C; Villegas G
Mech Dev; 2008; 125(5-6):558-68. PubMed ID: 18249526
[TBL] [Abstract][Full Text] [Related]
11. Signaling in regulation of podocyte phenotypes.
Chuang PY; He JC
Nephron Physiol; 2009; 111(2):p9-15. PubMed ID: 19142027
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.
Veron D; Reidy KJ; Bertuccio C; Teichman J; Villegas G; Jimenez J; Shen W; Kopp JB; Thomas DB; Tufro A
Kidney Int; 2010 Jun; 77(11):989-99. PubMed ID: 20375978
[TBL] [Abstract][Full Text] [Related]
13. Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease.
George B; Verma R; Soofi AA; Garg P; Zhang J; Park TJ; Giardino L; Ryzhova L; Johnstone DB; Wong H; Nihalani D; Salant DJ; Hanks SK; Curran T; Rastaldi MP; Holzman LB
J Clin Invest; 2012 Feb; 122(2):674-92. PubMed ID: 22251701
[TBL] [Abstract][Full Text] [Related]
14. Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation.
Bouvrée K; Brunet I; Del Toro R; Gordon E; Prahst C; Cristofaro B; Mathivet T; Xu Y; Soueid J; Fortuna V; Miura N; Aigrot MS; Maden CH; Ruhrberg C; Thomas JL; Eichmann A
Circ Res; 2012 Aug; 111(4):437-45. PubMed ID: 22723296
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor receptor 2 direct interaction with nephrin links VEGF-A signals to actin in kidney podocytes.
Bertuccio C; Veron D; Aggarwal PK; Holzman L; Tufro A
J Biol Chem; 2011 Nov; 286(46):39933-44. PubMed ID: 21937443
[TBL] [Abstract][Full Text] [Related]
16. Semaphorin3A regulates axon growth independently of growth cone repulsion via modulation of TrkA signaling.
Ben-Zvi A; Ben-Gigi L; Yagil Z; Lerman O; Behar O
Cell Signal; 2008 Mar; 20(3):467-79. PubMed ID: 18096366
[TBL] [Abstract][Full Text] [Related]
17. Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.
Veron D; Villegas G; Aggarwal PK; Bertuccio C; Jimenez J; Velazquez H; Reidy K; Abrahamson DR; Moeckel G; Kashgarian M; Tufro A
PLoS One; 2012; 7(7):e40589. PubMed ID: 22808199
[TBL] [Abstract][Full Text] [Related]
18. Out on a LIM: chronic kidney disease, podocyte phenotype and the Wilm's tumor interacting protein (WTIP).
Sedor JR; Madhavan SM; Kim JH; Konieczkowski M
Trans Am Clin Climatol Assoc; 2011; 122():184-97. PubMed ID: 21686224
[TBL] [Abstract][Full Text] [Related]
19. Dosage-dependent role of Rac1 in podocyte injury.
Wan X; Lee MS; Zhou W
Am J Physiol Renal Physiol; 2016 Apr; 310(8):F777-F784. PubMed ID: 26792065
[TBL] [Abstract][Full Text] [Related]
20. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.
Yamashita M; Yoshida T; Suzuki S; Homma K; Hayashi M
Clin Exp Nephrol; 2017 Feb; 21(1):16-26. PubMed ID: 27089875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
